Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA
Clinical trial NCT03600805 · TERMINATED
Trial details
- NCT number
- NCT03600805
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2020-11-24
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.